Today's COVID-19 News: April 7, 2020

Montefiore, Einstein Begin Coronavirus Treatment Trial

Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection. Read more...

Leica Biosystems Receives FDA Enforcement Discretion of Remote Diagnosis System

Leica Biosystems has received notification from the U.S. Food & Drug Administration (FDA) that its Aperio ImageScope DX Viewer with images acquired on the Aperio AT2 DX Scanner can be used for remote diagnosis under emergency use. Read more...

Trxade Group Files FDA Emergency Use Authorization for Rapid COVID-19 Testing Kit

Trxade Group has filed for an Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (FDA) in collaboration with its partnered manufacturer of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit. Read more...

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!

Vanda Initiates Study of Tradipitant in Hospitalized Patients with Severe COVID-19 Pneumonia

Vanda Pharmaceuticals announced the initiation of clinical study, ODYSSEY VLY-686-3501, in hospitalized patients with COVID-19. Read more...

BD, BioGX Announce FDA Emergency Use Authorization for COVID-19 Diagnostic Test

BD announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new diagnostic test that will enable hospitals to screen for COVID-19 (coronavirus) on site and get results in under three hours. Read more...

  • <<
  • >>

Join the Discussion